January 03, 2022
Video
Matt Henn, chief scientific officer at Seres Therapeutics, discusses new ways of targeting infectious diseases and antimicrobial resistant infections.
September 15, 2021
Article
Johnson & Johnson’s vaccine regimen induced neutralizing antibody responses in 98% of participants 21 days after the second dose.
August 27, 2021
The National Institutes of Health (NIH) announces single injection of monoclonal antibody against the Plasmodium mosquito-borne parasite prevented malaria throughout 9 month phase 1 trial.
August 10, 2021
The first case reported in Guinea has resulted in a patient's death, while health authorities work to reduce outbreak risks.
June 23, 2021
EVD outbreaks this year serve as a reminder of the virus’ severity and the importance of having a containment strategy in place.
June 21, 2021
The recombinant human IgG1κ monoclonal antibody binds and neutralizes the virus.
April 08, 2021
An outbreak which began at an infected healthcare worker's funeral has resulted in nearly 100 contact follow-ups.
March 11, 2021
Series completion rates were different among patient groups, the study authors observed.
February 15, 2021
This technology is effective in cases that are difficult to diagnose.
February 10, 2021
An assessment of a comparative study between leading options for a burdensome infection.
